Mercury Bio, Inc. research brief
CIK 1952927
Generated Nov. 17, 2026, 9:53 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: SANTA FE New Mexico. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Nov. 13, 2026 · D · 0001952927-26-000002 · Source evidence
Reported offering amount: 1589992 USD. Reported amount sold: 1589992 USD.
- Nov. 12, 2026 · D · 0001952927-26-000001 · Source evidence
Reported offering amount: 13268 USD. Reported amount sold: 13268 USD.
- Oct. 24, 2025 · D · 0001952927-25-000003 · Source evidence
Reported offering amount: 7954094 USD. Reported amount sold: 2376107 USD.
- Feb. 21, 2025 · D · 0001952927-25-000001 · Source evidence
Reported offering amount: 2541 USD. Reported amount sold: 2541 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Mercury Bio, Inc. research brief,” CIK 1952927, retrieved Nov. 17, 2026, 9:53 p.m.. Cite the specific accessions used. No amounts have been summed.